Press Release: Nocion : Nocion Therapeutics Advances to Clinical Stage and Expands Leadership

WALTHAM, Mass., Sept. 1, 2020 /PRNewswire/ -- Nocion Therapeutics (Nocion) announced today the dosing of the first subject in a healthy volunteer Phase 1 trial of NOC-100, an inhaled formulation of NTX-1175. NTX-1175 is a novel small molecule Charged Sodium Channel Blocker ("CSCB") being...